Category: News
EECA CAB addressed to Gilead Sciences, Merck Sharp&Dohme (MSD) and Bristol-Myers Squibb (BMS) with an open letter in which activists urge the companies to take immediate measures to ensure access to Atripla, fixed-dose combination of tenofovir, emtricitabine …
Community Advisory Board in Eastern Europe and Central Asia sent a letter to the Minister of Health of the Republic of Moldova to express its concern about the possible reduction in HIV program funding.
A meeting of Community Advisory Board in Eastern Europe and Central Asia was held in Kiev last week. This time treatment access activists from 9 countries of the region have met with representatives of the Medicines Patent …
The next meeting of the EECA CAB will be held October, 10-12th, 2013, in Kiev, Ukraine. Representatives of the pharmaceutical company Gilead Sciences and the Medicines Patent Pool will take part in the meeting; participating …
Treatment Action Group, TB-CAB, EECA CAB, India CAB, ITPCru, Non-Profit Partnership «E.V.A.» and Non-Profit Organization «Status-Plus» urge Alere to register rapid tests for active tuberculosis (TB-LAM antigen tests) in Eastern Europe and …
Janssen has responded to the request of the EECA activists to take measures aimed at improving access to the company’s products.
The fourth meeting of Eastern European and Central Asian Community Advisory Board (EECA CAB) took place in St. Petersburg.
May 29 — 31, the next meeting of EECA CAB will take place in St. Petersburg.
February 7, 2013, EECA CAB held a meeting attended by representatives of ViiV Healthcare. At the meeting, the company presented results of the latest clinical trials, information about the registration status of the drug products, voluntary licensing policy …
dThe activists of EECA sent an open letter to ViiV and Medicines Patent Pool regarding the agreement concluded between ViiV and MPP.
